查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539343

醫療影像設備市場：2024-2033年全球產業分析、規模、佔有率、成長、趨勢、預測

Medical Imaging Equipment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 143 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球醫學影像設備市場的深入研究報告，提供了有關驅動因素、趨勢、機會和挑戰等市場動態的詳細見解。本報告目的是提供對市場結構和未來前景的全面了解，尤其是醫療保健和醫療器材產業的利害關係人。

關鍵見解

  • 全球市場收入（2022年）：427億美元
  • 預計市場價值（2033年）：648億美元
  • 全球市場成長率（2022-2033年年複合成長率）：4.7%

全球醫療影像設備市場 - 報告範圍：

醫學影像設備市場涵蓋了用於診斷和監測各種疾病和狀況的各種設備。其中包括 X 光機、MRI 系統、超音波機、CT 掃描儀等。該市場是由對結核病、心血管疾病、骨科疾病等早期準確診斷的需求所推動的。

推動市場成長的因素：

結核病增加

結核病仍然是世界上主要的傳染病之一，對醫學影像設備的需求龐大，特別是在低收入和中等收入國家。根據世界衛生組織（WHO）統計，每年約有 1000萬人患有結核病，每年約有 150萬人死亡。大多數結核病病例集中在八個國家：孟加拉、中國、巴基斯坦、菲律賓、印尼、印度、奈及利亞和南非。這些地區結核病患者病率不斷上升，推動了對 X 光和 MRI 機器的需求，這對於結核病診斷和監測非常重要。

老年人口增加

世界老年人口快速成長，尤其是在新興市場。根據世界衛生組織估計，2019年60歲以上人口數量超過10億，預計2030年將達到14億，2050年將達20億。高齡化社會更容易受到各種健康問題的影響，包括結核病和肺炎等呼吸系統疾病、骨質疏鬆症等骨科疾病以及心血管疾病。對這些疾病進行早期、準確診斷的需求推動對醫學影像設備的需求。 X 光、超音波、MRI 和 CT 等技術對於診斷和管理這些與年齡相關的健康問題非常重要。

在資料管理中採用人工智慧

人工智慧（AI）與醫學影像的整合徹底改變該產業。人工智慧驅動的工具提高診斷成像過程的準確性和效率，實現更好的診斷和治療計劃。醫療影像領域資料管理中人工智慧的採用預計將推動市場成長，因為它可以實現更準確的影像處理、更快的分析並改善患者的治療結果。

產業協作與創新

醫療影像設備市場也受益於整個產業的協作和創新。例如，2022年 1月，O2 Investment Partners 將與 Modular Devices, Inc. 合作，支持該公司的發展並提供先進的診斷成像模式。這些合作預計將促進醫學影像處理技術的進一步進步，使其更易於使用和有效。

市場挑戰

高成本和基礎設施需求

醫療影像設備市場面臨的主要挑戰之一是設備及其支援所需的基礎設施成本高昂。 MRI 和 CT 掃描儀等先進影像技術需要大量投資，並且可能成為低收入和中等收入國家的障礙。此外，維護和操作這些設備需要專門的技能和設備，而這在某些地區可能不容易獲得。

監管和合規問題

醫學影像領域有嚴格的監管標準，以確保病患安全和設備有效性。遵守這些法規可能既複雜又耗時，特別是對於希望引進新技術或拓展新市場的公司。遵守這些法規非常重要，但它也會減緩新技術的採用並影響市場成長。

本報告解決的關鍵問題

  • 推動全球醫學影像設備市場成長的關鍵因素有哪些？
  • 哪些消費族群引領進成像技術的採用？
  • 技術進步與人工智慧整合如何影響競爭格局？
  • 誰是全球醫學影像設備市場的主要參與者？ 他們採取什麼策略來維持市場地位？
  • 全球醫學影像設備市場的新趨勢與未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第4章 關鍵成功因素

  • 產品採用率分析
  • 產品 USP/特點
  • 監理狀況
  • 安裝基礎場景
  • 最近核准的產品
  • 產品召回
  • 技術評估
  • 價值鏈分析
  • PESTLE分析
  • 波特的分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第6章 COVID-19 危機分析

  • 新冠肺炎（COVID-19）與影響分析
    • 依設備
    • 依方式
    • 依最終用戶
    • 依地區
  • 2024年市場情景

第7章 世界市場規模（單位）分析

  • 過去的數量（單位）分析，2019-2023年
  • 2024-2033年當前及未來數量（單位）預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第8章 世界市場 - 價格分析

  • 區域價格分析：依產品分類
  • 價格明細
    • 製造商等級定價
    • 經銷商級定價
  • 世界平均價格分析基準
  • 定價假設

第9章 全球市場需求（10億美元）分析

  • 過去市場價值分析（十億美元），2019-2023
  • 2024-2033年當前和未來市場價值（十億美元）的分析和預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第10章 世界市場分析：按設備

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（十億美元）和數量（單位）分析：按設備
  • 2024-2033年當前和未來市場規模（十億美元）和數量（單位）的分析和預測：按設備
    • 電腦斷層掃描（CT）系統
    • X射線系統
    • 核磁共振系統
    • 超音波系統
    • 核子造影裝置
    • 乳房X光檢查設備
    • 造影劑注射器
    • C 型臂/透視裝置
  • 市場吸引力分析：依設備分類

第11章 全球市場分析：按模式

  • 簡介/主要發現
  • 歷史市場規模（十億美元）分析：依模式，2019-2023年
  • 2024-2033年當前和未來市場規模（十億美元）的分析和預測：依模式
    • 獨立設備
    • 攜帶式設備
    • 手持設備
  • 市場吸引力分析：依方式分類

第12章 世界市場分析：依最終用戶

  • 簡介/主要發現
  • 歷史市場規模（十億美元）分析：依最終用戶，2019-2023年
  • 2024-2033年當前和未來市場規模（十億美元）的分析和預測：依最終用戶
    • 影像診斷中心
    • 門診手術中心
    • 專科診所
    • 調查機構
  • 市場吸引力分析：依最終用戶分類

第13章 世界市場分析：依地區

  • 簡介
  • 2019-2023年過往市場規模（十億美元）和數量（單位）分析：依地區
  • 2024-2033年當前和未來市場價值（十億美元）和數量（單位）的分析和預測：依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲（MEA）
  • 市場吸引力分析：依地區

第14章 北美市場分析

第15章 拉丁美洲市場分析

第16章 歐洲市場分析

第17章 東亞市場分析

第18章 南亞市場分析

第19章 大洋洲市場

第20章 中東與非洲（MEA）市場分析

第21章 市場結構分析

  • 市場分析：依公司層級
  • 主要公司市佔率分析
  • 市場現況分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳情
    • GE Healthcare
    • Hitachi Medical Corporation
    • Philips Healthcare
    • Siemens Healthineers
    • Toshiba Medical Systems Corporation
    • Esaote SpA
    • Positron Corporation
    • Neusoft Medical Systems
    • Neurologica Corporation
    • Mediso Medical Imaging Systems
    • Digirad
    • SHIMADZU CORPORATION
    • Hologic, Inc.
    • Guerbet SA
    • Bayer AG
    • Mallinckrodt
    • Bracco Imaging SpA
    • Ulrich GmbH &Co. KG
    • Medtron
    • Nemoto Kyorindo Co. Ltd
    • Lemer Pax

第23章 使用的先決條件與縮寫

第24章 研究方法

簡介目錄
Product Code: PMRREP11215

Persistence Market Research has recently published an in-depth report on the global medical imaging equipment market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the healthcare and medical device industries.

Key Insights:

  • Global Market Revenue (2022): US$ 42.7 Billion
  • Estimated Market Value (2033): US$ 64.8 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 4.7%

Global Medical Imaging Equipment Market - Report Scope:

The medical imaging equipment market covers a broad range of devices used in the diagnosis and monitoring of various diseases and conditions. These include X-ray machines, MRI systems, ultrasound devices, and CT scanners. The market is driven by the need for early and accurate diagnosis, particularly for conditions like tuberculosis, cardiovascular diseases, and orthopedic disorders.

Market Growth Drivers:

Growing Incidences of Tuberculosis (TB)

Tuberculosis (TB) remains one of the leading infectious diseases globally, with significant demand for medical imaging equipment, particularly in low- and middle-income countries. According to the World Health Organization (WHO), around 10 million people develop TB annually, with the disease claiming approximately 1.5 million lives each year. The majority of TB cases are concentrated in eight countries, including Bangladesh, China, Pakistan, the Philippines, Indonesia, India, Nigeria, and South Africa. The rising prevalence of TB in these regions is driving the demand for X-ray and MRI equipment, which are crucial for diagnosing and monitoring the disease.

Rising Geriatric Population

The global geriatric population is increasing at a rapid pace, particularly in emerging markets. According to WHO estimates, there were over 1 billion people aged 60 and above in 2019, with this number expected to reach 1.4 billion by 2030 and 2 billion by 2050. The aging population is more susceptible to a range of health issues, including respiratory diseases (such as tuberculosis and pneumonia), orthopedic conditions (like osteoporosis), and cardiovascular diseases. The need for early and accurate diagnosis of these conditions is driving demand for medical imaging equipment. Technologies such as X-ray, ultrasound, MRI, and CT are essential for diagnosing and managing these age-related health issues.

Adoption of AI in Data Management

The integration of artificial intelligence (AI) into medical imaging is revolutionizing the industry. AI-driven tools are enhancing the accuracy and efficiency of imaging processes, enabling better diagnosis and treatment planning. The adoption of AI in data management within the medical imaging sector is expected to drive market growth, as it allows for more precise imaging, faster analysis, and improved patient outcomes.

Industry Collaborations and Innovations

The medical imaging equipment market is also benefiting from industry-wide collaborations and innovations. For instance, in January 2022, O2 Investment Partners collaborated with Modular Devices, Inc. to support the company's growth and provide advanced imaging modalities. Such partnerships are expected to drive further advancements in medical imaging technology, making it more accessible and effective.

Market Challenges:

High Costs and Infrastructure Requirements

One of the significant challenges facing the medical imaging equipment market is the high cost of devices and the infrastructure needed to support them. Advanced imaging technologies such as MRI and CT scanners require substantial investment, which can be a barrier in low- and middle-income countries. Additionally, the maintenance and operation of these devices require specialized skills and facilities, which may not be readily available in all regions.

Regulatory and Compliance Issues

The medical imaging sector is subject to strict regulatory standards to ensure patient safety and device efficacy. Navigating these regulations can be complex and time-consuming, particularly for companies looking to introduce new technologies or expand into new markets. Compliance with these regulations is essential, but it can also slow down the adoption of new technologies and impact market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global medical imaging equipment market?
  • Which consumer segments are leading the adoption of advanced imaging technologies?
  • How are technological advancements and AI integration influencing the competitive landscape?
  • Who are the key players in the global medical imaging equipment market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global medical imaging equipment market?

Competitive Intelligence and Business Strategy:

Leading players in the global medical imaging equipment market, such as Siemens Healthineers, GE Healthcare, and Philips Healthcare, are focusing on product innovation, strategic collaborations, and expanding their presence in emerging markets. These companies are investing heavily in research and development to create advanced imaging technologies that offer enhanced diagnostic capabilities and better patient outcomes. Partnerships and collaborations are also playing a key role in driving innovation and expanding the reach of these technologies globally.

Key Companies Profiled:

  • GE Healthcare
  • Hitachi Medical Corporation
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation
  • Esaote S.p.A
  • Positron Corporation
  • Neusoft Medical Systems
  • Neurologica Corporation
  • Mediso Medical Imaging Systems
  • Digirad
  • SHIMADZU CORPORATION
  • Hologic, Inc.
  • Guerbet SA
  • Bayer AG
  • Mallinckrodt
  • Bracco Imaging S.p.A
  • Ulrich GmbH & Co. KG
  • Medtron
  • Nemoto Kyorindo Co. Ltd
  • Lemer Pax

Key Segments Covered in Medical Imaging Equipment Industry Research

Equipment:

  • Computed Tomography (CT) Systems
  • X-ray Systems
  • MRI Systems
  • Ultrasound Systems
  • Nuclear Imaging Equipment
  • Mammography Equipment
  • Contrast Media Injectors
  • C-Arms & Fluoroscopy Devices

Modality:

  • Stand-Alone Devices
  • Portable Devices
  • Hand-Held Devices

End User:

  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Product USPs/ Features
  • 4.3. Regulatory Landscape
  • 4.4. Install Base Scenario
  • 4.5. Recent Product Approved
  • 4.6. Product Recall
  • 4.7. Technology Assessment
  • 4.8. Value Chain Analysis
  • 4.9. PESTLE Analysis
  • 4.10. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Medical Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising incidence of chronic diseases
    • 5.2.2. Rising Demand in Emerging Economies for Imaging Technologies
    • 5.2.3. Growing Advancements in Maneuverability and Imaging Capabilities
    • 5.2.4. Adoption of alternative techniques
    • 5.2.5. Strategic mergers and acquisitions
    • 5.2.6. Favorable Reimbursement scenario
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Equipment
    • 6.1.2. By Modality
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Volume (in Units) Analysis, 2019-2023
  • 7.2. Current and Future Volume (in Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Equipment

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Equipment, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Equipment, 2024-2033
    • 10.3.1. Computed Tomography (CT) Systems
      • 10.3.1.1. 256-320 slice CT Systems
      • 10.3.1.2. 128-slice CT Systems
      • 10.3.1.3. 64-slice CT Systems
      • 10.3.1.4. 16-slice and below CT Systems
    • 10.3.2. X-ray Systems
      • 10.3.2.1. Analog X-ray Systems
      • 10.3.2.2. Digital X-ray Systems
        • 10.3.2.2.1. Computed Radiography (CR) Systems
        • 10.3.2.2.2. Digital Radiography (DR) Systems
        • 10.3.2.2.3. Retrofit X-ray Systems
    • 10.3.3. MRI Systems
      • 10.3.3.1. 0.7 T MRI Systems
      • 10.3.3.2. 1.5 T MRI Systems
      • 10.3.3.3. 3 T MRI Systems
      • 10.3.3.4. 7 T MRI Systems
      • 10.3.3.5. Others
    • 10.3.4. Ultrasound Systems
      • 10.3.4.1. Black & White Ultrasound Systems
      • 10.3.4.2. Color Doppler Ultrasound Systems
    • 10.3.5. Nuclear Imaging Equipment
      • 10.3.5.1. Positron Emission Tomography (PET) Systems
        • 10.3.5.1.1. PET Scanners
        • 10.3.5.1.2. PET/CT
        • 10.3.5.1.3. PET/MRI
      • 10.3.5.2. Single-Photon Emission Computed Tomography
        • 10.3.5.2.1. Single Imaging Gamma Cameras
        • 10.3.5.2.2. SPECT/CT
    • 10.3.6. Mammography Equipment
      • 10.3.6.1. Film-Screen Mammography Equipment
      • 10.3.6.2. 2D Digital Mammography Equipment
      • 10.3.6.3. 3D Tomosynthesis
    • 10.3.7. Contrast Media Injectors
      • 10.3.7.1. CT Injectors
      • 10.3.7.2. MRI Injectors
      • 10.3.7.3. Cardio Injectors
      • 10.3.7.4. PET Injectors
    • 10.3.8. C-Arms & Fluoroscopy Devices
      • 10.3.8.1. C-Arms Systems
        • 10.3.8.1.1. Full Size C - arms Systems
        • 10.3.8.1.2. Mini C - arms Systems
      • 10.3.8.2. Fluoroscopy Devices
  • 10.4. Market Attractiveness Analysis, by Equipment

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Modality, 2024-2033
    • 11.3.1. Stand-Alone Devices
    • 11.3.2. Portable Devices
    • 11.3.3. Hand-Held Devices
  • 11.4. Market Attractiveness Analysis, by Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 12.3.1. Diagnostic Imaging Centers
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Specialty Clinics
    • 12.3.4. Research Institutes
  • 12.4. Market Attractiveness Analysis, by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Equipment
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Equipment
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Equipment
        • 14.7.1.2.2. By Modality
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Equipment
        • 14.7.2.2.2. By Modality
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Equipment
    • 15.3.3. By Modality
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Equipment
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Mexico Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Equipment
        • 15.7.1.2.2. By Modality
        • 15.7.1.2.3. By End User
    • 15.7.2. Brazil Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Equipment
        • 15.7.2.2.2. By Modality
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Equipment
        • 15.7.3.2.2. By Modality
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Equipment
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Equipment
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Equipment
        • 16.7.1.2.2. By Modality
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Equipment
        • 16.7.2.2.2. By Modality
        • 16.7.2.2.3. By End User
    • 16.7.3. France Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Equipment
        • 16.7.3.2.2. By Modality
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Equipment
        • 16.7.4.2.2. By Modality
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.5.2.1. By Equipment
        • 16.7.5.2.2. By Modality
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.6.2.1. By Equipment
        • 16.7.6.2.2. By Modality
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.7.2.1. By Equipment
        • 16.7.7.2.2. By Modality
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Equipment
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Equipment
    • 17.4.2. By Modality
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Equipment
        • 17.7.1.2.2. By Modality
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Equipment
        • 17.7.2.2.2. By Modality
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.3.2.1. By Equipment
        • 17.7.3.2.2. By Modality
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Equipment
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Equipment
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Equipment
        • 18.7.1.2.2. By Modality
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Equipment
        • 18.7.2.2.2. By Modality
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Equipment
        • 18.7.3.2.2. By Modality
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Equipment
        • 18.7.4.2.2. By Modality
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Equipment
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Equipment
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.1.2.1. By Equipment
        • 19.7.1.2.2. By Modality
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.2.2.1. By Equipment
        • 19.7.2.2.2. By Modality
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Equipment
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Equipment
    • 20.4.2. By Modality
    • 20.4.3. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.1.2.1. By Equipment
        • 20.7.1.2.2. By Modality
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.2.2.1. By Equipment
        • 20.7.2.2.2. By Modality
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.3.2.1. By Equipment
        • 20.7.3.2.2. By Modality
        • 20.7.3.2.3. By End User
    • 20.7.4. North Africa Market Analysis
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.4.2.1. By Equipment
        • 20.7.4.2.2. By Modality
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis, by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. GE Healthcare
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Hitachi Medical Corporation
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Philips Healthcare
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Siemens Healthineers
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. Toshiba Medical Systems Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Esaote S.p.A
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Positron Corporation
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Neusoft Medical Systems
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Neurologica Corporation
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Mediso Medical Imaging Systems
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Digirad
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Financials
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. SHIMADZU CORPORATION
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Financials
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Hologic, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Financials
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. Guerbet SA
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Financials
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy
    • 22.3.15. Bayer AG
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Sales Footprint
      • 22.3.15.4. Key Financials
      • 22.3.15.5. SWOT Analysis
      • 22.3.15.6. Strategy Overview
        • 22.3.15.6.1. Marketing Strategy
        • 22.3.15.6.2. Product Strategy
        • 22.3.15.6.3. Channel Strategy
    • 22.3.16. Mallinckrodt
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Sales Footprint
      • 22.3.16.4. Key Financials
      • 22.3.16.5. SWOT Analysis
      • 22.3.16.6. Strategy Overview
        • 22.3.16.6.1. Marketing Strategy
        • 22.3.16.6.2. Product Strategy
        • 22.3.16.6.3. Channel Strategy
    • 22.3.17. Bracco Imaging S.p.A
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Sales Footprint
      • 22.3.17.4. Key Financials
      • 22.3.17.5. SWOT Analysis
      • 22.3.17.6. Strategy Overview
        • 22.3.17.6.1. Marketing Strategy
        • 22.3.17.6.2. Product Strategy
        • 22.3.17.6.3. Channel Strategy
    • 22.3.18. Ulrich GmbH & Co. KG
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Sales Footprint
      • 22.3.18.4. Key Financials
      • 22.3.18.5. SWOT Analysis
      • 22.3.18.6. Strategy Overview
        • 22.3.18.6.1. Marketing Strategy
        • 22.3.18.6.2. Product Strategy
        • 22.3.18.6.3. Channel Strategy
    • 22.3.19. Medtron
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Sales Footprint
      • 22.3.19.4. Key Financials
      • 22.3.19.5. SWOT Analysis
      • 22.3.19.6. Strategy Overview
        • 22.3.19.6.1. Marketing Strategy
        • 22.3.19.6.2. Product Strategy
        • 22.3.19.6.3. Channel Strategy
    • 22.3.20. Nemoto Kyorindo Co. Ltd
      • 22.3.20.1. Overview
      • 22.3.20.2. Product Portfolio
      • 22.3.20.3. Sales Footprint
      • 22.3.20.4. Key Financials
      • 22.3.20.5. SWOT Analysis
      • 22.3.20.6. Strategy Overview
        • 22.3.20.6.1. Marketing Strategy
        • 22.3.20.6.2. Product Strategy
        • 22.3.20.6.3. Channel Strategy
    • 22.3.21. Lemer Pax
      • 22.3.21.1. Overview
      • 22.3.21.2. Product Portfolio
      • 22.3.21.3. Sales Footprint
      • 22.3.21.4. Key Financials
      • 22.3.21.5. SWOT Analysis
      • 22.3.21.6. Strategy Overview
        • 22.3.21.6.1. Marketing Strategy
        • 22.3.21.6.2. Product Strategy
        • 22.3.21.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology